Polpharma Group B.V.
Inga Jezewska serves as the Group Chief Financial Officer at Polpharma Group since January 2025, previously holding the position of Vice President of Group Corporate Finance at Sonova Group from February 2023 to January 2025. Inga has extensive experience in corporate finance, business planning, and financial reporting, demonstrated during tenure as Vice President and Global Head of Business Planning and Analysis at Novartis Oncology, and various senior financial roles at Baxter International Inc., including Vice President of Global Head Financial Reporting and Accounting Operations. Prior experience includes a Director of Finance position at Damovo and an auditing role at Ernst & Young. Inga holds a Fellow Certified Chartered Accountant designation and an Executive MBA from UQAM, alongside a Master in Economics from the University of Lodz.
This person is not in any teams
This person is not in any offices
Polpharma Group B.V.
Polpharma Group is one of the leading healthcare companies in CEE, Central Asia and Russia. All our efforts are focused on delivering high-quality and affordable medicines to as many communities as possible. Every day we diligently cooperate with doctors, pharmacists and other healthcare professionals to better understand every stage of a patient’s journey and ensure that our patients receive and stick to the most adequate treatment. Thanks to best-in-class industry talents and state-of-the-art technologies, we are able to design and deliver crucial products and solutions to address the biggest health challenges (an ageing population, outbreaks of chronic diseases, growing volatility) and healthcare system problems (increasing healthcare costs, resource shortages). Through collaboration with our partners, we explore new ways of doing business and accelerate positive changes. We are guided by more than just business results and ambitious goals – our purpose that constantly motivates us and drives our actions and further development.